{
    "2018-05-03": [
        [
            {
                "time": "2018-04-01",
                "original_text": "Abbott Laboratories’ Strong Organic Growth Momentum in 1Q18",
                "features": {
                    "keywords": [
                        "Strong",
                        "Organic Growth",
                        "Momentum",
                        "1Q18"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-03-25",
                "original_text": "ABT’s Recent Stock Slump: What’s behind the Decline?",
                "features": {
                    "keywords": [
                        "Stock Slump",
                        "Decline"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-03-20",
                "original_text": "Analysts’ Recent Recommendations and Target Price for ABT Stock",
                "features": {
                    "keywords": [
                        "Recommendations",
                        "Target Price"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-02-15",
                "original_text": "Abbott Expands Cardiac Arrhythmias Portfolio with FDA Clearance of Advanced Mapping Catheter",
                "features": {
                    "keywords": [
                        "Expands",
                        "Cardiac Arrhythmias",
                        "FDA Clearance",
                        "Advanced Mapping Catheter"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}